Ontario Institute for Cancer Research

27 articles about Ontario Institute for Cancer Research

• Intensity Therapeutics, The Ottawa Hospital and Ontario Institute for Cancer Research Report INT230-6 Demonstrates Tumor Necrosis and Immune Activation in Early Stage Breast Cancers

  11/10/2022

  Intensity Therapeutics, Inc. along with The Ottawa Hospital and Ontario Institute of Cancer Research, will present updated data from the INVINCIBLE study, a randomized, phase 2 presurgical window of opportunity trial for Intensity's intratumoral INT230-6 comprising SHAO, vinblastine and cisplatin, that is evaluating clinical and biological effects in patients with early-stage operable breast cancer.

• Intensity Therapeutics, The Ottawa Hospital and The Ontario Institute for Cancer Research Report INT230-6 Demonstrates Tumor Necrosis and Immune Activation in Early Stage Breast Cancers

  6/6/2022

  The Ottawa Hospital, The Ontario Institute of Cancer Research and Intensity Therapeutics, Inc. presented data from the INVINCIBLE study, a randomized, phase 2 presurgical Window-Of-Opportunity trial for Intratumoral INT230-6 comprising SHAO, VINblastine and Cisplatin that is evaluating clinical and Biological Effects in patients with early-stage operable breast cancer.

• 

  Clinical Catch-Up: March 22-26

  3/29/2021

  There was a fair amount of clinical trial news last week. Here’s a look.
• 

  Research Roundup: Genomic Dark Matter Mutation and More

  10/18/2019

  Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.

• Canadian Government-Sponsored Collaboration Targets Standardized Cancer Testing

  7/30/2019

  Genome Canada, Ontario Institute for Cancer Research and Thermo Fisher Scientific to focus on pancreatic, prostate and breast cancer

• Ontario Institute for Cancer Research Launches Five Large-Scale Ontario Research Initiatives To Combat Some Of The Most Deadly Cancers

  5/24/2017

• Ontario Institute for Cancer Research Release: New Findings Published Today In Nature Challenge Current View Of How Pancreatic Cancer Develops

  10/13/2016

• Ontario Institute for Cancer Research Release: Researchers Discover Protein Signatures For Accurate Non-Invasive Diagnosis Of Aggressive Prostate Cancer

  6/28/2016

• Ontario Institute for Cancer Research Release: Clinical Trial Launched To Test Use Of MRI To Improve Prostate Cancer Diagnosis And Management

  6/1/2016

• Ontario Institute for Cancer Research Release: The Canadian Cancer Clinical Trials Network Launches Ask Me Campaign To Raise Awareness Of Cancer Clinical Trials

  5/4/2016

• Ontario Institute for Cancer Research Congratulates Dr. John Dick On His Election As A 2016 Fellow Of The AACR Academy

  4/7/2016

• Ontario Institute for Cancer Research Release: International Cancer Genome Consortium Reaches Milestone Of 1,000 Authorized Users

  3/1/2016

• Ontario Institute for Cancer Research Release: Real Time Outbreak Surveillance Using Genomics Now Possible In Resource-Limited Conditions

  2/3/2016

• Ontario Institute for Cancer Research Invests $1.2 Million To Support Oncology Drug Development In Ontario

  1/7/2016

• The Ontario Institute for Cancer Research And The Structural Genomics Consortium Develop And Give Away New Drug-Like Molecule To Help Crowd-Source Cancer Research

  9/3/2015

• Ontario Institute for Cancer Research Release: Cancer Patients Treated In World-First Clinical Trial Of Canadian Viral Therapy

  7/10/2015

• The Ontario Institute for Cancer Research Invests $4.6 Million To Support Pancreatic Cancer Research

  6/1/2015

• Personalized Genetic Test To Predict Prostate Cancer Recurrence Risk, Ontario Institute for Cancer Research Study

  11/13/2014

• Ontario Institute for Cancer Research Release: Ontario Researchers Discover New Test To Better Personalize Treatment For Prostate Cancer

  11/13/2014

• Ontario Institute for Cancer Research Release: Researchers Discover New Gene Mutation To Improve Diagnosis And Treatment Of Salivary Gland Cancer

  10/29/2014